FORM 4
[ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Johnston Richard C. 		2. Issuer Name and Ticker or Trading Symbol

USMD Holdings, Inc. [ USMD ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Chief Physician Officer
(Last)          (First)          (Middle)

7301 SUMMITVIEW 		3. Date of Earliest Transaction (MM/DD/YYYY)

9/30/2016
(Street)

IRVING, TX 75063
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock ($.01 par value)   9/30/2016     D    10579   D   (1) 0   D    
Common Stock ($.01 par value)   9/30/2016     J    2600   D $10.00   (2) 30084   I   Indirectly held through UANT Ventures, L.P.  
Common Stock ($.01 par value)   9/30/2016     D    30084   D   (3) 0   I   Indirectly held through UANT Ventures, L.P.  
Common Stock ($.01 par value)   9/30/2016     D    397   D   (1) 0   I   Indirectly held through Las Colinas Medical Group  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
( 1)  Disposed of at the effective time of the merger of Project Z Merger Sub, Inc. ("Merger Sub"), a wholly-owned subsidiary of WellMed Medical Management, Inc., a Texas corporation ("WellMed"), with and into the issuer (the "Merger"), pursuant to that certain Agreement and Plan of Merger dated August 29, 2016, between the issuer, WellMed and Merger Sub, in exchange for a cash payment of $22.34 per share.
( 2)  Dr. Johnston sold a portion of the partnership interests he held in UANT Ventures, L.P. ("Ventures"), which resulted in a decrease in his indirect beneficial ownership of the shares of the issuer's common stock held by Ventures.
( 3)  Upon the disposition of its shares of the issuer's common stock at the effective time of the Merger, Ventures received a cash payment of $22.34 per share. After paying certain Merger-related costs, each partner of Ventures, including the reporting person, received a distribution equal to $22.22 per share (subject to certain post-closing adjustments) for the shares of the issuer's common stock such person held indirectly through Ventures.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Johnston Richard C.
7301 SUMMITVIEW
IRVING, TX 75063

Chief Physician Officer

Signatures
/s/ Richard C. Johnston 10/4/2016
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Usmd Holdings, Inc. (MM) (NASDAQ:USMD)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Usmd Holdings, Inc. (MM) Charts.
Usmd Holdings, Inc. (MM) (NASDAQ:USMD)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Usmd Holdings, Inc. (MM) Charts.